Form4insider filings, from the source

SEC Form 4 · accession 0001852291-26-000004

BeOne Medicines Ltd. · ONC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Lai Wang
Officer — President, Global Head of R&D
Period of report
Jun 8, 2026
Accepted (ET)
Jun 10, 2026 · 5:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001651308

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
American Depositary SharesF5,F7Jun 8, 2026S1,327$269.3426D40D
American Depositary SharesF5Jun 8, 2026S40$270.73D0D
Ordinary Sharesholding———1,601,288D
Ordinary SharesF1holding———601,965ISee Footnote
RMB SharesF2,F3,F4holding———0ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses